Characteristics and Long-Term Efficacy of 25 Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab or Ravulizumab in Taiwan

被引：0
|
作者：
Lin, Hsing-Yu [1 ]
Chen, Yu-Wen [1 ]
Yu, Ta-Chuan [2 ]
Tien, Feng-Ming [3 ,4 ]
Lin, Chien-Chin [4 ,5 ]
Chou, Sheng-Chieh [4 ]
Wu, Shang-Ju [4 ]
Ko, Bor-Sheng [4 ,6 ]
Yang, Yung-Li [7 ,8 ]
Yao, Ming [4 ]
Tsay, Woei [4 ]
Tien, Hwei-Fang [4 ,9 ]
Hou, Hsin-An [4 ]
Chou, Wen-Chien [4 ,5 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Yunlin Branch, Dept Internal Med, Yunlin, Taiwan
[3] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
[6] Natl Taiwan Univ, Canc Ctr, Dept Hematol Oncol, Taipei, Taiwan
[7] Natl Taiwan Univ, Canc Ctr, Dept Lab Med, Taipei, Taiwan
[8] Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan
[9] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-199918
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5672 / 5673
页数：2
相关论文
共 50 条
  • [41] Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies
    Kulasekararaj, Austin G.
    Griffin, Morag
    Langemeijer, Saskia
    Usuki, Kensuke
    Kulagin, Alexander
    Ogawa, Masayo
    Yu, Ji
    Mujeebuddin, Arshad
    Nishimura, Jun-ichi
    Lee, Jong Wook
    de Latour, Regis Peffault
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (03) : 205 - 214
  • [42] Real-World Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Eculizumab or Ravulizumab in the US: A Retrospective Claims Database Analysis
    Tantravahi, Srinivas
    Latremouille-Viau, Dominick
    Desai, Raj
    Lee, Soyon
    Paulose, Jincy
    Geevarghese, Anumaxine
    Guerin, Anne
    Seshasayee, Shravanthi
    Chanpura, Mohin
    Yen, Glorian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S599 - S599
  • [43] Efficacy and Safety of Eculizumab in Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria
    Reiss, Ulrike M.
    Schwartz, Jeffrey
    Sakamoto, Kathleen M.
    Puthenveetil, Geetha
    Ogawa, Masayo
    Ware, Russell E.
    BLOOD, 2011, 118 (21) : 477 - 478
  • [44] Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
    Bhak, Rachel
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 190 - 190
  • [45] Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
    Bhak, Rachel H.
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher W.
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (11) : 1913 - 1923
  • [46] Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis
    Karadag, Fatma Keklik
    Yenerel, Mustafa Nuri
    Yilmaz, Mehmet
    Uskudar, Hava
    Ozkocaman, Vildan
    Tuglular, Tulin Firatli
    Erdem, Fuat
    Unal, Ali
    Ayyildiz, Orhan
    Ozet, Gulsum
    Comert, Melda
    Kaya, Emin
    Ayer, Mesut
    Salim, Ozan
    Guvenc, Birol
    Ozdogu, Hakan
    Mehtap, Ozgur
    Sonmez, Mehmet
    Guler, Nil
    Hacioglu, Sibel
    Aydogdu, Ismet
    Bektas, Ozlen
    Toprak, Selami Kocak
    Kaynar, Lale
    Yagci, Munci
    Aksu, Salih
    Tombak, Anil
    Karakus, Volkan
    Yavasoglu, Irfan
    Onec, Birgul
    Ozcan, Mehmet Ali
    Undar, Levent
    Ali, Ridvan
    Ilhan, Osman
    Saydam, Guray
    Sahin, Fahri
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2021, 11 (03): : 279 - 285
  • [47] Survival benefit of eculizumab in patients with paroxysmal nocturnal hemoglobinuria
    Patel, Ami
    Metzger, Jesse
    Terriou, Louis
    Patriquin, Christopher
    Griffin, Morag
    Lee, Jong Wook
    Gustovic, Phillippe
    Jiang, Wei
    Szer, Jeff
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 264 - 265
  • [48] Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Previously Treated with Eculizumab: A Matching-Adjusted Indirect Comparison
    Bhak, Rachel Y.
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    BLOOD, 2020, 136
  • [49] Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea
    Kim, Jin Seok
    Jang, Jun Ho
    Jo, Deog-Yeon
    Ahn, Seo-Yeon
    Yoon, Sung-Soo
    Lee, Je-Hwan
    Kim, Sung-Hyun
    Choi, Chul Won
    Shin, Ho-Jin
    Kim, Min-Kyoung
    Lee, Jae Hoon
    Mun, Yeung-Chul
    Kong, Jee Hyun
    Hyun, BokJin
    Nam, HyunSun
    Kim, Eunhye
    Kwak, Min Joo
    Won, Yong Kyun
    Lee, Jong Wook
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (41) : 1 - 12
  • [50] Long-Term Survival Benefit of Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria: Data from the International PNH Registry
    Terriou, Louis
    Patriquin, Christopher J.
    Griffin, Morag
    Lee, Jong Wook
    Gustovic, Philippe
    Patel, Ami S.
    Szer, Jeff
    BLOOD, 2021, 138
12345